Company Name:ImmunoGen Inc.
CEO: Mark J. Enyedy

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Immunogen Inc is a clinical-stage biotechnology company that develops targeted anticancer therapeutics. It has developed its ADC technology to enable the creation of anticancer products.


Key numbers

Market Capitalization:495490450
Shares Outstanding: 149695000
Float: 147472029.25
Next Earning Date:2020-02-10
TTm EPS: -1.0091
TTm Dividend Rate:
200 days moving average:2.82
50 days moving average: 2.83
One day percent Change: 2.42



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-06-30, 2016-06-30, 2017-12-31, 2018-12-31,
2015-06-30, 2016-06-30, 2017-12-31, 2018-12-31,